Tag: FDA generics
Perception vs Reality: Why Generics Seem Less Effective Than Brand-Name Drugs
- By : Tamsin Riverton
- Date : Feb 24 2026
Generics are scientifically identical to brand-name drugs, yet many people believe they’re less effective. This article explains why the perception gap exists, how it affects health outcomes, and what you can do about it.
Tentative Approval for Generics: Common Reasons for Delays
- By : Tamsin Riverton
- Date : Dec 21 2025
Tentative approval from the FDA means a generic drug is scientifically ready - but not yet legal to sell. Common delays include patent lawsuits, manufacturing issues, and market economics that prevent launch even after approval.
Infographics About Generics: Visual Education Tools for Patient Understanding
- By : Tamsin Riverton
- Date : Dec 10 2025
Infographics about generics help patients understand that generic drugs are just as safe and effective as brand-name versions. With clear visuals, the FDA’s tools explain bioequivalence, manufacturing standards, and cost savings-reducing skepticism and improving adherence.
